Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-30

FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ferriprox (deferiprone) submitted by Chiesi USA, Inc. This action approves changes to the product under the suppleme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERRIPROX (deferiprone)

Snippet

SUPPL AP for FERRIPROX (DEFERIPRONE)